Healthcare costs are record-high, evidenced by the fact that over 900 prescription drugs saw price increases in January alone. Meanwhile, legislative bodies are struggling to address the complexities of drug pricing legislation. Amid these challenges, innovation is starting to show promising signs. Xevant, a pharmaceutical analytics platform, is a testament to what technology and vision can achieve in pursuit of making healthcare more affordable for all Americans. With its sophisticated platform, Xevant is not just part of the conversation about achieving the lowest net-cost drugs; it is leading the charge.